TrialCancer research communications2025

BrUOG360: A Phase Ib/II Study of Copanlisib in Combination with Rucaparib in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC).

Andre L De Souza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.